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Worldwide, iron deficiency is a common form of micronutrient deficiency with a high individual and societal cost. There are
considerable knowledge and practice gaps in the diagnosis and treatment of iron deficiency. Bibliometric analysis examines the
published body of knowledge of a subject in an objective fashion. The Web of Science Core Collection was searched to retrieve
the 100 most cited papers on the topic of iron deficiency, and the key metrics of each paper were extracted. A keyword study
was performed using VOSviewer 1.6.10 software, which provided a visual mapping of the network of keyword cooccurrences.
The papers were published between 1964 and 2017 and were cited an average of 636 times. They were contributed by authors
from 119 different countries/regions, with the largest contributing country being the United States. 29 institutions contributed at
least 6 publications each, and 4 researchers authored or coauthored at least 5 papers. Keyword analysis suggests that the most
cited topics could be grouped into 4 categories: (1) epidemiologic research of the global burden of iron deficiency, (2) clinical
aspects of iron deficiency anemia, (3) iron metabolism, and (4) the impact of iron deficiency on children. Identification of the
most impactful studies in the field of iron deficiency may be helpful to practitioners interested in improving their knowledge
base. Compared to bibliometric studies performed on other topics, the medical literature of iron deficiency is mature, as
evidenced by the high citation rate of the top 100 papers. Despite the high worldwide prevalence of iron deficiency, the top cited
papers are dominated by a relatively small number of countries and institutions. Interestingly, however, the most cited authors
in this study do not overlap with the most cited institutions.
1. Background
Iron deficiency is a common micronutrient deficiency, with
an estimated prevalence of approximately one-third of the
world population, and is thus one of the most commonly
encountered abnormalities in general medical practice [1].
Although its most common clinical manifestation is a
microcytic, hypochromic anemia, iron deficiency can affect
a diverse range of systems including the central nervous sys-
tem and reticuloendothelial system and has clinical conse-
quences ranging from impaired immunity, cognitive
deficits, decreased exercise capacity, and decreased quality of
life as measured by disability-adjusted life years. Apart from
its influence on individual health, iron deficiency has a pro-
found economic impact due to impaired work capacity [2].
The field of iron deficiency is a rich one: a search of the
Web of Science Core Collection (WoSCC, All Fields, search
term “iron deficiency”) conducted on 28 December 2020
yielded 23,694 results. Despite the fact that iron deficiency
is commonly encountered in the clinical setting, studies have
shown considerable practice and knowledge gaps [3]. Such
issues could be addressed using a bibliometric methodology
to assess landmark studies in the history of iron deficiency
research. A bibliometric study examines the published scien-
tific body of knowledge of a given subject in an objective
fashion. The purpose of this approach is to summarize the
current state of the subject, examine the development of a
research field, and provide guidance for future research.
Although it was originally conceived as a research tool, bib-
liometric analysis may be of interest to any reader interested
in the scope and interrelatedness of a given area of
knowledge.
The WoSCC has features that make it particularly useful
as a tool for bibliometric analyses. To date, there has been no
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comprehensive review of studies of iron deficiency using bib-
liometric methodology. The purpose of this study was to
examine the 100 most cited papers on iron deficiency using
data from the WoSCC. The data provide a comprehensive
view of the current research status of iron deficiency by utiliz-
ing the year of publication, citation number, authors, coun-
try/region, organizations, journals, and other important
features of these studies. The keywords from these papers
were mapped using VOSviewer (Leiden University) software
to demonstrate the main areas of interest in this field and
their interrelations.
2. Methods
This study was performed using a standard bibliometric
methodology, similar to that described by Lu et al. [4], and
was performed using Preferred Reporting Items for System-
atic Reviews and Meta-analysis (PRISMA) standards (see
Supplementary Data File S1, which contains the PRISMA
checklist).
2.1. Data Sources. The 100 most cited iron deficiency-related
papers were retrieved from the WoSCC database, with no
restriction on the date of publication. The search strategy
used the search term “iron deficiency” in all fields with only
publications indexed as “ARTICLE” or “REVIEW” being
included. All hits were ranked by the number of citations.
2.2. Data Extraction. The author assessed the full text of each
identified paper to ensure that the study referred to iron defi-
ciency in humans. The following information was obtained
for each study: title, publication year, publication type, num-
ber of citations, authors, countries/region, institutions, jour-
nals, and their impact factors (IFs). For studies originating
from more than one country and/or institution, the country
and institution listed in the Web of Science entry were used.
2.3. Statistical Analysis. Microsoft Excel 2016 software (Red-
mond, Washington, USA) was used for descriptive statistical
analyses of year of publication, publication type, number of
citations, author names, countries/regions, organizations,
and journals and their IFs (as listed in the 2020 Journal Cita-
tion Reports of Clarivate Analytics) [4]. VOSviewer 1.6.10
software (Leiden University) was used to map the network
of keyword cooccurrence (the unit of analysis was set to
“All keywords”). In the map, each circle represents a term,
the size of which indicates how often it appeared. If keywords
appeared together in any of the 100 papers, a line connected
the two circles; the thicker the line, the greater the number of
times they appeared together. The greater the frequency of
the two terms appearing together, the closer the two circles
would be [5]. The resolution of the term map was set for least
7 times in the 100 papers.
3. Results
The 100 most cited papers in the field of iron deficiency iden-
tified in the WoSCC consisted of 67 original articles and 33
review articles. The total number of citations per paper
ranged from 308 to 3877, with the mean number of citations
being 636 (median = 472 citations). 46% of articles had >500
citations, and 9% had >1000 citations. Supplementary Data
File S2 summarizes the data for the top 100 cited papers,
organized according to number of citations and including
first author name, journal, year, volume, issue, page numbers,
and number of citations.
3.1. Year of Publication. The papers in the present study were
published between 1964 and 2017. The year with the largest
number of published studies was 2008. Figure 1 presents
the temporal distribution of the top 100 cited papers.
3.2. Distribution of Countries/Regions. The papers were con-
tributed by authors from 119 countries/regions. Authors
from 25 countries/regions contributed to at least 6 publica-
tions each (Table 1); the countries with the largest numbers
of publications were the United States (71 publications),
England (25 publications), Switzerland (15 publications),
France (13 publications), and Italy (12 publications).
3.3. Distribution of Institutions. Of the institutions identified
in the paper, 18 contributed at least 7 publications each
(Table 2). The top 4 organizations were the University of
California System, Harvard University, the University of




































































Figure 1: Temporal distribution of papers in this study. Two years (1964 and 2017) are off scale and are not shown.
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3.4. Distribution of Authors. 631 individuals authored or
coauthored at least 2 times, and 4 researchers authored or
coauthored at least 5 papers in the list. The authors appearing
in 5 or more publications are B Lozoff (University of
Michigan, Ann Arbor, Michigan, USA, 6 publications), R
Lozano (Instituto Nacional de Salud Publica, Cuernavaca,
Morelos, Mexico, 5 publications), CJL Murray (University
of Washington, Seattle, Washington, USA, 5 publications),
and M Naghavi (University of Washington, Seattle,
Washington, USA, 5 publications).
3.5. Distribution of Journals. Overall, the papers in this study
were published in 47 academic journals. Table 3 lists the jour-
nals (n = 15) where the largest number of studies was pub-
lished. The IF for the journals that published ≥2 papers
ranged from 60.392 (Lancet) to 4.281 (Journal of Nutrition).
These journals are published in the USA (11/15, 73%) and
the United Kingdom (4/15, 27%). The largest number of
papers was published by Lancet (17 papers), American Jour-
nal of Clinical Nutrition (6 papers), and Blood (6 papers).
3.6. Cooccurrence of Keywords. Overall, 58 terms appeared 7
times or more in the titles or abstracts of the top 100 papers
(Figure 2). For example, “iron deficiency” appeared 48 times,
“iron” appeared 33 times, “iron deficiency anemia” appeared
31 times, “effect” appeared 28 times, and “anemia” appeared
24 times. Based on this, the terms or phrases associated with
iron deficiency are divided into 4 clusters, represented by 4
colors (red, green, blue, and yellow). From the results of
cooccurrences, current iron deficiency research mainly
focused on 4 major areas. These are (1) epidemiologic
research investigating the global burden of iron deficiency
(red), (2) research into the clinical aspects of iron deficiency
anemia (green), (3) iron metabolism (blue), and (4) the
impact of iron deficiency on children (yellow). These 4 topics
may be regarded as the current research hotspots in the field
of iron deficiency. The terms that appeared at least ten times
are listed in Table 4.
4. Discussion
4.1. The Bibliometric Approach Applied to Iron Deficiency.
This bibliometric study focuses on the 100 most cited papers
related to iron deficiency research, which were published
between 1964 and 2017. The purpose of this study was to
evaluate the research status and trends in the field of iron
deficiency research. The counties with the highest degree of
representation in this study were the USA, England, Switzer-
land, France, and Italy with more than 10 publications each,
whereas further 13 countries published at least 7 studies each
between 1964 and 2017. The dominance of the USA in this
research may be due to funding of basic and clinical research
by groups such as the Department of Veterans Affairs and the
National Institutes of Health. The University of California
System and Harvard University contributed the most papers
to this list, likely due to the broad interest of researchers at
these multicampus academic systems in basic and clinical
science regarding iron deficiency. Interestingly, the top-
cited organizations did not overlap with the top-cited
authors.
In addition to the high mean citation number, 9 papers
were cited over 1000 times, and the lowest-cited paper was
cited 308 times. The high citation impact of the top 100
papers suggests that iron deficiency is a mature research field.
Using a similar methodology to the current study, the top 100
papers in drug therapy for ventilator-associated pneumonia
and coronary artery disease had similar high citation num-
bers [6, 7], whereas an emerging field such as network phar-
macology had a much lower number of papers with high
citation rate and a larger delta between the highest and lowest
cited papers [4]. The top 100 cited papers were published in
47 journals, among which 3 journals (Lancet, American Jour-
nal of Clinical Nutrition, and Blood) published over one-
quarter of the papers included in this list. Most of the jour-
nals in which the top 100 cited papers were published are
published in the USA and England and are generally within
the fields of general and internal medicine and nutrition
(see S2).
According to the results of keyword cooccurrence, the
100 most cited papers covered the main topics of iron defi-
ciency research, including its applications and common
research methods. The current research hotspots are (1) epi-
demiologic research investigating the global burden of iron
deficiency, (2) research into the clinical aspects of iron
Table 1: Distribution of papers by country/region. Countries




























deficiency anemia, (3) iron metabolism, and (4) the impact of
iron deficiency on children. This is supported by the opinions
of the authors of recent reviews in the field [8–11].
4.2. Epidemiology of Iron Deficiency. Iron deficiency was
studied as a part of the Global Burden of Disease Study, a
large-scale observational epidemiologic survey looking at
289 diseases and injuries and conducted from 1990 to the
present. Four of the top 5 cited papers in the current study
were published as part of this study [12–15]. Populations at
increased risk of iron deficiency include persons in develop-
ing countries, individuals from lower socioeconomic classes
in developed countries, and women [16–20]. Worldwide,
approximately 2 billion people are anemic, of whom ~50%
are iron deficient [21].
The World Health Organization estimates that the prev-
alence of anemia in the developing world is 39% for
children < 5 years old, 48% in children between 5 and 14
years old, and 52% in pregnant women, of which approxi-
mately 50% is due to iron deficiency [22]. However, Modell
and Darlison addressed a significant problem in assessing
populations for estimated prevalence of iron deficiency ane-
mia in developing nations. Since populations in these parts
of the world may have an increased prevalence of thalasse-
mia, it is important to use hemoglobin ranges specific for
these populations. Using published ranges, which are pre-
dominantly drawn from patients of Northern European ori-
gin, may lead to an overestimate of iron deficiency [23].
Older populations also demonstrate an elevated risk of
anemia; a study from the USA by Guralnik et al. estimates
Table 2: Distribution of papers by organization. Organizations contributing >6 papers are shown.
Organization Records
University of California System 30
Harvard University 15
University of London 14
University of Michigan 14
Johns Hopkins University 11
University College London 9
US Department of Veterans Affairs 9
Veterans Health Administration VHA 9
Columbia University 8
Imperial College London 8
University of Texas System 8
Case Western Reserve University 7
Emory University 7
Johns Hopkins Bloomberg School of Public Health 7
London School of Hygiene Tropical Medicine 7
Pennsylvania Commonwealth System of Higher Education PCSHE 7
Table 3: Journals publishing >1 of the papers in this study, impact factor, and country in which the journal is published.
Source Titles records Impact factor Country
Lancet 17 60.392 UK
American Journal of Clinical Nutrition 6 6.766 USA
Blood 6 17.543 USA
Gastroenterology 5 17.373 USA
Journal of Nutrition 5 4.281 USA
New England Journal of Medicine 5 74.699 USA
Pediatrics 5 5.359 USA
Annual Review of Nutrition 3 10.897 USA
Nature 3 42.778 UK
Nature Genetics 3 27.603 UK
American Journal of Gastroenterology 2 10.171 USA
American Journal of Kidney Diseases 2 6.618 USA
Clinical Chemistry 2 7.292 USA
Gut 2 19.819 UK
JAMA Journal of the American Medical Association 2 45.540 USA
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that approximately 10% of individuals over age 65 are ane-
mic, of which half have anemia due to iron deficiency [24].
4.3. Clinical Features of Iron Deficiency. Iron deficiency may
be caused by increased iron need, low iron intake, decreased
iron absorption, or chronic blood loss [9]. In addition,
chronic inflammatory conditions may predispose to the
development of iron deficiency [9].
Several papers in the current study have evaluated the
etiology of iron deficiency. Decreased iron absorption
may be seen in patients with Helicobacter pylori gastritis,
chronic use of nonsteroidal anti-inflammatory drugs, and
celiac disease due to consequent mucosal damage [25–31].
Iron deficiency is also a common complication of bariatric
surgery [32].
Among the chronic inflammatory conditions placing
individuals at risk of iron deficiency, one of the best studied
has been heart failure. The 2017 clinical practice guidelines
for the management of chronic heart failure state that treat-
ment of iron-depleted patients with intravenous iron resulted
in quality of life improvement and better exercise capacity
[33]. In the developing world, chronic inflammation associ-
ated with parasitic infection is a common cause of iron
deficiency anemia. For example, hookworm infection is
responsible for up to 73% of severe iron deficiency anemia
in Africa [34].
Anemia is also a common complication of chronic kid-
ney disease due to a variety of mechanisms including
decreased dietary absorption due to excess hepcidin or iron
deficiency due to reticuloendothelial system iron blockade
[35, 36]. In response to iron deficiency, the body’s absorption
of lead, cadmium, and aluminum increases. The widespread
consequences of increased levels of these minerals include
adverse effects to the central nervous system, kidney, and
skeletal system [37–39].
Iron deficiency also has widespread adverse effects on
immunity, including impairment of B-cell and T-cell func-
tion and decreased phagocytosis and macrophage killing
power [40]. Iron deficiency is associated with increased risk
of malaria and increased morbidity from infection [41].
Iron deficiency is common in women with heavy menses
due to blood loss and during pregnancy due to increased iron
uptake by the developing fetus. As a result, iron supplemen-
tation is commonly prescribed to women of childbearing age
and during pregnancy. An important consideration in the
latter case is the increased potential for adverse maternal
effects such as gestational diabetes, which have been linked
to prophylactic iron supplementation [42].
The treatment and prevention of iron deficiency vary
depending on the underlying cause. Dietary supplementation
with iron-rich foods is an important strategy, particularly in
developing countries and in individuals with restricted diets
(e.g., vegans) [43]. Genetic modification of plants to enhance
the bioavailability of iron may be important, particularly in
areas where meat consumption is limited [44]. Iron supple-
ments may be taken orally or in the case of ferric carboxymal-
tose administered intravenously [45–47]. In patients with
Helicobacter pylori gastritis and celiac disease, treatment of
the underlying condition may result in correction of anemia
[25, 27–29].
4.4. Iron Metabolism and Laboratory Diagnosis of Iron
Deficiency Anemia. Not surprisingly, the clinical features of
iron deficiency and iron metabolism show considerable over-
lap in Figure 2, with some terms (e.g., “ferritin” and “serum
ferritin”) in the clinical feature region and others (e.g., “hep-
cidin” and “gene”) in the iron metabolism region. The high-
est cited paper that addresses iron metabolism is a seminal
study by Nicolas et al., which, along with subsequent work,
defined and characterized the gene encoding the hepcidin
protein and its regulation by anemia, hypoxia, and inflamma-
tion [48–51]. Another highly cited paper is the 2000 study by
Abboud and Haile that reported the discovery characteriza-
tion of the mtp1 gene, the expression of which is upregulated
in the duodenum iron deficiency and regulates intracellular
iron metabolism [52].
Figure 2: Mapping of 58 keywords occurring >7 times in papers in this study.
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The laboratory diagnosis of iron deficiency can generally
be made using a blood specimen. Chemistry-based assays
have been shown to be more sensitive than the assessment
of red blood cell indices, since a substantial proportion of
iron-deficient individuals do not have decreased mean cor-
puscular volume [1]. A battery of serum tests including ferri-
tin (a measure of iron stores) and transferrin saturation (a
measure of bioavailable iron) is most often employed. In iron
deficiency, decreased serum ferritin and transferrin satura-
tion is expected [53, 54]. The use of serum ferritin was advo-
cated by Siimes et al. as early as 1974 [55]. Ferritin is of
proven utility in the assessment of iron stores. In a study by
Guyatt et al., in which serum ferritin was compared to the
gold standard, iron stain of bone marrow aspirate material,
a ferritin level of ≤30μg/L was of acceptable sensitivity and
specificity for the detection of iron deficiency even in patients
without anemia [56]. The ratio of serum transferrin receptor
to serum ferritin, a potentially useful laboratory test for
whole body iron stores, is limited by lack of standardization
of serum transferrin receptor assays [53, 57, 58]. Other bio-
markers of iron deficiency have been proposed. Serum hepci-
din is potentially useful to distinguish iron deficiency anemia
from anemia of chronic disease (inflammation) but has not
been widely studied for this application [1]. It can be used
in the diagnosis of iron-refractory iron deficiency anemia, a
recessive disease due to mutation of the hepcidin inhibitor
TMPRSS6, but is mainly available in referral centers [50,
59–61]. Reticulocyte hemoglobin content, which is a param-
eter measured by several commercially available cell ana-
lyzers, is of potential use in the diagnosis of iron deficiency
anemia, although studies of its clinical applicability are
currently limited [62].
4.5. Issues in Children. The health consequences of iron defi-
ciency for infants and children have been well studied. In this
study, the most cited paper was the first in an influential
series of review articles on maternal and child malnutri-
tion published in Lancet [63]. Subsequent papers in this
series addressed the risk factors associated with iron defi-
ciency and other nutritional deficiencies and potential
interventions that could be employed to improve outcomes
in children [64–67].
Infants born to iron-deficient mothers are at increased
risk of low birth weight and prematurity [42, 68, 69]. In addi-
tion, infants and children with iron deficiency are at
increased risk of defects in neural development, manifested
as poor motor development, impaired cognitive develop-
ment, and behavioral issues [64, 70, 71]. This is demonstrated
in a study by Lozoff et al. reviewing data from Costa Rica,
which found that children with hemoglobin levels ≤ 10 g/dL
were particularly affected [72]. These issues are not markedly
improved despite iron supplementation and can have mea-
surable effects even up to 10 years after correction of iron
deficiency [72–74]. Iron deficiency is a concern in adoles-
cence. Halterman et al. noted decreased standardized test
scores in adolescent girls with iron deficiency even in the
absence of anemia [75].
One possible mechanism for the central nervous system
impairment associated with iron deficiency anemia is its
effects on oligodendrocytes, the principal iron-containing
cells of the brain. In the presence of iron deficiency, phenom-
ena such as impaired myelination and oxidative injury may
occur [76, 77].
4.6. Advantages and Disadvantages of the Bibliometric
Method. Our study has the following advantages. First, this
is the first study using bibliometric methodology to summa-
rize the status and development of the top 100 cited papers
related to iron deficiency. Second, the top 100 cited papers
related to iron deficiency in this study could be considered
as benchmarks in the evolution of the field. The key papers
that were retrieved by combining the reports from the
WoSCC database were reviewed to ensure the accuracy and
completeness of the dataset. However, like other bibliometric
studies, it has limitations [4]. First, the features of the
WoSCC database that allow its metadata to be used for bib-
liometric studies are not shared with other databases, such
Table 4: Keywords occurring >9 times in papers in this study, with
corresponding number of occurrences and link strength.
Term Occurrences Link strength
Iron deficiency 48 346
Iron 33 268
























Iron deficiency anemia 10 96
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as PubMed, Embase, and Scopus. Thus, the studies were
drawn from a single database. However, it is important to
note that bibliometric analysis and keyword mapping are
best approached using material from the WoSCC database
[78]. Second, it would be a reasonable assumption that the
citation frequency of studies published earlier should be
greater than that of more recently published studies; there-
fore, potentially influential studies have not been considered
due to their relatively low citation number. Third, other fac-
tors such as the IF of individual journals, authors, reputation,
and institutions may influence whether a given study is cited.
5. Conclusion
This is a bibliometric study of the top 100 cited papers related
to iron deficiency. The papers were published from 1964 to
2017. Based on the results from bibliometric analysis, it is
clear that iron deficiency research is mainly focused on 4
areas: epidemiologic research investigating the global burden
of iron deficiency, research into the clinical aspects of iron
deficiency anemia, iron metabolism, and the impact of iron
deficiency on children. The USA and England published
the most highly cited papers in these areas. This study
provides, for the first time, insights into the historical
development and research status of iron deficiency using a
bibliometric methodology.
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